<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> are at increased risk of developing <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The combinations of the haplotype created by the alleles of three single nucleotide polymorphisms (SNPs): SNP-43, -19, and -63 of the Calpain-10 gene (CAPN10), have been reported to be associated with the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in many populations </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to examine the association of the CAPN10 polymorphism with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in Korea </plain></SENT>
<SENT sid="3" pm="."><plain>Overall, 382 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were enrolled in this study </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the subjects were genotyped according to CAPN10 SNP-43, -19, and -63 </plain></SENT>
<SENT sid="5" pm="."><plain>The restriction fragment length polymorphism method was used for the three SNPs </plain></SENT>
<SENT sid="6" pm="."><plain>The baseline presence of components of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> was determined </plain></SENT>
<SENT sid="7" pm="."><plain>Two hundred and sixty-five (69.4%) patients had <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with the 111/121 haplotype combination showed a higher risk of <z:hpo ids='HP_0000822'>hypertension</z:hpo> than the other haplotype combinations (odd ratio (OR)=2.334, P=0.010) </plain></SENT>
<SENT sid="9" pm="."><plain>Patients with the 111/121 haplotype combination had a significantly high risk of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (OR=1.927, P=0.042) </plain></SENT>
<SENT sid="10" pm="."><plain>The results of this study suggest that a novel 111/121 haplotype combination created by the CAPN10 SNP-43, -19, and -63 increases the susceptibility to the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>